The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Virtual Screening for Drug Discovery Market Research Report 2025

Global Virtual Screening for Drug Discovery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1977667

No of Pages : 95

Ask Your Query
Synopsis
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Virtual Screening for Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Virtual Screening for Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Virtual Screening for Drug Discovery in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Virtual Screening for Drug Discovery include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Virtual Screening for Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Screening for Drug Discovery.
The Virtual Screening for Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Virtual Screening for Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virtual Screening for Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MedChemExpress
TargetMol
OpenEye Scientific
Eurofins Discovery
Sygnature Discovery
Jubilant Biosys
Schrödinger, Inc.
Cresset Group
ComputaBio
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
CKTTDB
HitGen
WuXi AppTec
LeadBuilder
CSNpharm
ChemNavigator
Segment by Type
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Hybrid Methods
Segment by Application
Pharmaceutical Company
Universities and Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virtual Screening for Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Structure-based Virtual Screening (SBVS)
1.2.3 Ligand-based Virtual Screening (LBVS)
1.2.4 Hybrid Methods
1.3 Market by Application
1.3.1 Global Virtual Screening for Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Universities and Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Screening for Drug Discovery Market Perspective (2019-2030)
2.2 Global Virtual Screening for Drug Discovery Growth Trends by Region
2.2.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Virtual Screening for Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Virtual Screening for Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Virtual Screening for Drug Discovery Market Dynamics
2.3.1 Virtual Screening for Drug Discovery Industry Trends
2.3.2 Virtual Screening for Drug Discovery Market Drivers
2.3.3 Virtual Screening for Drug Discovery Market Challenges
2.3.4 Virtual Screening for Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Screening for Drug Discovery Players by Revenue
3.1.1 Global Top Virtual Screening for Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Virtual Screening for Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Virtual Screening for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Virtual Screening for Drug Discovery Revenue
3.4 Global Virtual Screening for Drug Discovery Market Concentration Ratio
3.4.1 Global Virtual Screening for Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Screening for Drug Discovery Revenue in 2023
3.5 Global Key Players of Virtual Screening for Drug Discovery Head office and Area Served
3.6 Global Key Players of Virtual Screening for Drug Discovery, Product and Application
3.7 Global Key Players of Virtual Screening for Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Screening for Drug Discovery Breakdown Data by Type
4.1 Global Virtual Screening for Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Virtual Screening for Drug Discovery Breakdown Data by Application
5.1 Global Virtual Screening for Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Virtual Screening for Drug Discovery Market Size (2019-2030)
6.2 North America Virtual Screening for Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Virtual Screening for Drug Discovery Market Size by Country (2019-2024)
6.4 North America Virtual Screening for Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virtual Screening for Drug Discovery Market Size (2019-2030)
7.2 Europe Virtual Screening for Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Virtual Screening for Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Virtual Screening for Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Virtual Screening for Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Virtual Screening for Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Virtual Screening for Drug Discovery Market Size (2019-2030)
9.2 Latin America Virtual Screening for Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Virtual Screening for Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Virtual Screening for Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Screening for Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Virtual Screening for Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MedChemExpress
11.1.1 MedChemExpress Company Details
11.1.2 MedChemExpress Business Overview
11.1.3 MedChemExpress Virtual Screening for Drug Discovery Introduction
11.1.4 MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.1.5 MedChemExpress Recent Development
11.2 TargetMol
11.2.1 TargetMol Company Details
11.2.2 TargetMol Business Overview
11.2.3 TargetMol Virtual Screening for Drug Discovery Introduction
11.2.4 TargetMol Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.2.5 TargetMol Recent Development
11.3 OpenEye Scientific
11.3.1 OpenEye Scientific Company Details
11.3.2 OpenEye Scientific Business Overview
11.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Introduction
11.3.4 OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.3.5 OpenEye Scientific Recent Development
11.4 Eurofins Discovery
11.4.1 Eurofins Discovery Company Details
11.4.2 Eurofins Discovery Business Overview
11.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Introduction
11.4.4 Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.4.5 Eurofins Discovery Recent Development
11.5 Sygnature Discovery
11.5.1 Sygnature Discovery Company Details
11.5.2 Sygnature Discovery Business Overview
11.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Introduction
11.5.4 Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.5.5 Sygnature Discovery Recent Development
11.6 Jubilant Biosys
11.6.1 Jubilant Biosys Company Details
11.6.2 Jubilant Biosys Business Overview
11.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Introduction
11.6.4 Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.6.5 Jubilant Biosys Recent Development
11.7 Schrödinger, Inc.
11.7.1 Schrödinger, Inc. Company Details
11.7.2 Schrödinger, Inc. Business Overview
11.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Introduction
11.7.4 Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.7.5 Schrödinger, Inc. Recent Development
11.8 Cresset Group
11.8.1 Cresset Group Company Details
11.8.2 Cresset Group Business Overview
11.8.3 Cresset Group Virtual Screening for Drug Discovery Introduction
11.8.4 Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.8.5 Cresset Group Recent Development
11.9 ComputaBio
11.9.1 ComputaBio Company Details
11.9.2 ComputaBio Business Overview
11.9.3 ComputaBio Virtual Screening for Drug Discovery Introduction
11.9.4 ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.9.5 ComputaBio Recent Development
11.10 Profacgen
11.10.1 Profacgen Company Details
11.10.2 Profacgen Business Overview
11.10.3 Profacgen Virtual Screening for Drug Discovery Introduction
11.10.4 Profacgen Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.10.5 Profacgen Recent Development
11.11 CD ComputaBio
11.11.1 CD ComputaBio Company Details
11.11.2 CD ComputaBio Business Overview
11.11.3 CD ComputaBio Virtual Screening for Drug Discovery Introduction
11.11.4 CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.11.5 CD ComputaBio Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Virtual Screening for Drug Discovery Introduction
11.12.4 Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 BOC Sciences
11.13.1 BOC Sciences Company Details
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences Virtual Screening for Drug Discovery Introduction
11.13.4 BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.13.5 BOC Sciences Recent Development
11.14 CKTTDB
11.14.1 CKTTDB Company Details
11.14.2 CKTTDB Business Overview
11.14.3 CKTTDB Virtual Screening for Drug Discovery Introduction
11.14.4 CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.14.5 CKTTDB Recent Development
11.15 HitGen
11.15.1 HitGen Company Details
11.15.2 HitGen Business Overview
11.15.3 HitGen Virtual Screening for Drug Discovery Introduction
11.15.4 HitGen Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.15.5 HitGen Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Details
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Virtual Screening for Drug Discovery Introduction
11.16.4 WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.16.5 WuXi AppTec Recent Development
11.17 LeadBuilder
11.17.1 LeadBuilder Company Details
11.17.2 LeadBuilder Business Overview
11.17.3 LeadBuilder Virtual Screening for Drug Discovery Introduction
11.17.4 LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.17.5 LeadBuilder Recent Development
11.18 CSNpharm
11.18.1 CSNpharm Company Details
11.18.2 CSNpharm Business Overview
11.18.3 CSNpharm Virtual Screening for Drug Discovery Introduction
11.18.4 CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.18.5 CSNpharm Recent Development
11.19 ChemNavigator
11.19.1 ChemNavigator Company Details
11.19.2 ChemNavigator Business Overview
11.19.3 ChemNavigator Virtual Screening for Drug Discovery Introduction
11.19.4 ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
11.19.5 ChemNavigator Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Structure-based Virtual Screening (SBVS)
Table 3. Key Players of Ligand-based Virtual Screening (LBVS)
Table 4. Key Players of Hybrid Methods
Table 5. Global Virtual Screening for Drug Discovery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Virtual Screening for Drug Discovery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Virtual Screening for Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Virtual Screening for Drug Discovery Market Share by Region (2019-2024)
Table 9. Global Virtual Screening for Drug Discovery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Virtual Screening for Drug Discovery Market Share by Region (2025-2030)
Table 11. Virtual Screening for Drug Discovery Market Trends
Table 12. Virtual Screening for Drug Discovery Market Drivers
Table 13. Virtual Screening for Drug Discovery Market Challenges
Table 14. Virtual Screening for Drug Discovery Market Restraints
Table 15. Global Virtual Screening for Drug Discovery Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Virtual Screening for Drug Discovery Market Share by Players (2019-2024)
Table 17. Global Top Virtual Screening for Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2023)
Table 18. Ranking of Global Top Virtual Screening for Drug Discovery Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Virtual Screening for Drug Discovery Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Virtual Screening for Drug Discovery, Headquarters and Area Served
Table 21. Global Key Players of Virtual Screening for Drug Discovery, Product and Application
Table 22. Global Key Players of Virtual Screening for Drug Discovery, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Virtual Screening for Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Virtual Screening for Drug Discovery Revenue Market Share by Type (2019-2024)
Table 26. Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Virtual Screening for Drug Discovery Revenue Market Share by Type (2025-2030)
Table 28. Global Virtual Screening for Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Virtual Screening for Drug Discovery Revenue Market Share by Application (2019-2024)
Table 30. Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Virtual Screening for Drug Discovery Revenue Market Share by Application (2025-2030)
Table 32. North America Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Virtual Screening for Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Virtual Screening for Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Virtual Screening for Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Virtual Screening for Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Virtual Screening for Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Virtual Screening for Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Virtual Screening for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 47. MedChemExpress Company Details
Table 48. MedChemExpress Business Overview
Table 49. MedChemExpress Virtual Screening for Drug Discovery Product
Table 50. MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 51. MedChemExpress Recent Development
Table 52. TargetMol Company Details
Table 53. TargetMol Business Overview
Table 54. TargetMol Virtual Screening for Drug Discovery Product
Table 55. TargetMol Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 56. TargetMol Recent Development
Table 57. OpenEye Scientific Company Details
Table 58. OpenEye Scientific Business Overview
Table 59. OpenEye Scientific Virtual Screening for Drug Discovery Product
Table 60. OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 61. OpenEye Scientific Recent Development
Table 62. Eurofins Discovery Company Details
Table 63. Eurofins Discovery Business Overview
Table 64. Eurofins Discovery Virtual Screening for Drug Discovery Product
Table 65. Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 66. Eurofins Discovery Recent Development
Table 67. Sygnature Discovery Company Details
Table 68. Sygnature Discovery Business Overview
Table 69. Sygnature Discovery Virtual Screening for Drug Discovery Product
Table 70. Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 71. Sygnature Discovery Recent Development
Table 72. Jubilant Biosys Company Details
Table 73. Jubilant Biosys Business Overview
Table 74. Jubilant Biosys Virtual Screening for Drug Discovery Product
Table 75. Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 76. Jubilant Biosys Recent Development
Table 77. Schrödinger, Inc. Company Details
Table 78. Schrödinger, Inc. Business Overview
Table 79. Schrödinger, Inc. Virtual Screening for Drug Discovery Product
Table 80. Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 81. Schrödinger, Inc. Recent Development
Table 82. Cresset Group Company Details
Table 83. Cresset Group Business Overview
Table 84. Cresset Group Virtual Screening for Drug Discovery Product
Table 85. Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 86. Cresset Group Recent Development
Table 87. ComputaBio Company Details
Table 88. ComputaBio Business Overview
Table 89. ComputaBio Virtual Screening for Drug Discovery Product
Table 90. ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 91. ComputaBio Recent Development
Table 92. Profacgen Company Details
Table 93. Profacgen Business Overview
Table 94. Profacgen Virtual Screening for Drug Discovery Product
Table 95. Profacgen Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 96. Profacgen Recent Development
Table 97. CD ComputaBio Company Details
Table 98. CD ComputaBio Business Overview
Table 99. CD ComputaBio Virtual Screening for Drug Discovery Product
Table 100. CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 101. CD ComputaBio Recent Development
Table 102. Creative Biolabs Company Details
Table 103. Creative Biolabs Business Overview
Table 104. Creative Biolabs Virtual Screening for Drug Discovery Product
Table 105. Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 106. Creative Biolabs Recent Development
Table 107. BOC Sciences Company Details
Table 108. BOC Sciences Business Overview
Table 109. BOC Sciences Virtual Screening for Drug Discovery Product
Table 110. BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 111. BOC Sciences Recent Development
Table 112. CKTTDB Company Details
Table 113. CKTTDB Business Overview
Table 114. CKTTDB Virtual Screening for Drug Discovery Product
Table 115. CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 116. CKTTDB Recent Development
Table 117. HitGen Company Details
Table 118. HitGen Business Overview
Table 119. HitGen Virtual Screening for Drug Discovery Product
Table 120. HitGen Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 121. HitGen Recent Development
Table 122. WuXi AppTec Company Details
Table 123. WuXi AppTec Business Overview
Table 124. WuXi AppTec Virtual Screening for Drug Discovery Product
Table 125. WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 126. WuXi AppTec Recent Development
Table 127. LeadBuilder Company Details
Table 128. LeadBuilder Business Overview
Table 129. LeadBuilder Virtual Screening for Drug Discovery Product
Table 130. LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 131. LeadBuilder Recent Development
Table 132. CSNpharm Company Details
Table 133. CSNpharm Business Overview
Table 134. CSNpharm Virtual Screening for Drug Discovery Product
Table 135. CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 136. CSNpharm Recent Development
Table 137. ChemNavigator Company Details
Table 138. ChemNavigator Business Overview
Table 139. ChemNavigator Virtual Screening for Drug Discovery Product
Table 140. ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 141. ChemNavigator Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
Table 145. Authors List of This Report


List of Figures
Figure 1. Virtual Screening for Drug Discovery Picture
Figure 2. Global Virtual Screening for Drug Discovery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Virtual Screening for Drug Discovery Market Share by Type: 2023 VS 2030
Figure 4. Structure-based Virtual Screening (SBVS) Features
Figure 5. Ligand-based Virtual Screening (LBVS) Features
Figure 6. Hybrid Methods Features
Figure 7. Global Virtual Screening for Drug Discovery Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Virtual Screening for Drug Discovery Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Universities and Research Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. Virtual Screening for Drug Discovery Report Years Considered
Figure 13. Global Virtual Screening for Drug Discovery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Virtual Screening for Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Virtual Screening for Drug Discovery Market Share by Region: 2023 VS 2030
Figure 16. Global Virtual Screening for Drug Discovery Market Share by Players in 2023
Figure 17. Global Top Virtual Screening for Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Virtual Screening for Drug Discovery Revenue in 2023
Figure 19. North America Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Virtual Screening for Drug Discovery Market Share by Country (2019-2030)
Figure 21. United States Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Virtual Screening for Drug Discovery Market Share by Country (2019-2030)
Figure 25. Germany Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Virtual Screening for Drug Discovery Market Share by Region (2019-2030)
Figure 33. China Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Virtual Screening for Drug Discovery Market Share by Country (2019-2030)
Figure 41. Mexico Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Virtual Screening for Drug Discovery Market Share by Country (2019-2030)
Figure 45. Turkey Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Virtual Screening for Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. MedChemExpress Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 49. TargetMol Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 50. OpenEye Scientific Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 51. Eurofins Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 52. Sygnature Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 53. Jubilant Biosys Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 54. Schrödinger, Inc. Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 55. Cresset Group Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 56. ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 57. Profacgen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 58. CD ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 59. Creative Biolabs Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 60. BOC Sciences Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 61. CKTTDB Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 62. HitGen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 63. WuXi AppTec Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 64. LeadBuilder Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 65. CSNpharm Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 66. ChemNavigator Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock